Association of Serum Ferritin With Severity of Disease in Real-Time Reverse Transcription-Polymerase Chain Reaction Negative COVID-19 Patients

• Published in: Curēus (Palo Alto, CA) CA), 2023-06, Vol.15 (6), p.e41065-e41065
• Main Authors: Sai Bharath, Boyina V, Tudu, Promod K, Dash, Subhash C, Sahoo, Nalinikanta
• Format: Article
• Language: English
• Subjects: Cardiovascular disease; Chronic obstructive pulmonary disease; COVID-19; Emergency Medicine; Internal Medicine; Mortality
• ISSN: 2168-8184; 2168-8184
• DOI: 10.7759/cureus.41065

Coronavirus disease 2019 (COVID-19) is still causing disastrous effects in various parts of the world through recurring waves. Real-time reverse transcription polymerase chain reaction (RT-PCR)-negative COVID-19 is particularly challenging as these patients are less likely to receive treatment and more likely to progress to severe disease. Thus, it is imperative to find markers that can predict the severity of disease at an early stage. The objective of the present study was to analyze the association of ferritin levels with severe disease in RT-PCR-negative COVID-19 patients. A prospective cross-sectional analytical study was conducted in adults with COVID-19 pneumonia with a negative RT-PCR test from October 2020 to September 2021. Hematologic, biochemical, and inflammatory parameters were investigated within 24 h of hospitalization. Demographic, clinical, and laboratory findings were compared between patients with and without severe disease. A total of 220 patients were included. The mean age of the study participants was 47.3 ± 14.2 years, and 55.5% (n=122) were male. C-reactive protein, D-dimer, and ferritin levels were significantly higher in patients with severe disease (p